Telesis Bio, Inc. TBIO
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -46.76% | -23.45% | -17.05% | 19.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -46.76% | -23.45% | -17.05% | 19.98% |
| Cost of Revenue | -- | -27.59% | -36.46% | -34.76% | -22.65% |
| Gross Profit | -- | -57.47% | -14.38% | -3.60% | 66.78% |
| SG&A Expenses | -- | -18.90% | -19.29% | -14.67% | -2.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -25.19% | -27.79% | -24.03% | -15.40% |
| Operating Income | -- | 8.99% | 30.40% | 28.15% | 30.17% |
| Income Before Tax | -- | -21.17% | 5.77% | 5.12% | 31.06% |
| Income Tax Expenses | -- | 5.26% | 9.52% | 0.00% | 22.73% |
| Earnings from Continuing Operations | -- | -21.16% | 5.77% | 5.12% | 31.03% |
| Earnings from Discontinued Operations | -- | -145.73% | -308.47% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -24.31% | 2.49% | 1.54% | 27.75% |
| EBIT | -- | 8.99% | 30.40% | 28.15% | 30.17% |
| EBITDA | -- | 10.75% | 32.80% | 30.37% | 32.30% |
| EPS Basic | -- | -26.80% | -0.11% | 0.30% | 27.25% |
| Normalized Basic EPS | -- | 11.92% | 48.08% | 44.89% | 45.32% |
| EPS Diluted | -- | -26.80% | -0.11% | 0.30% | 27.25% |
| Normalized Diluted EPS | -- | 11.92% | 48.08% | 44.89% | 45.32% |
| Average Basic Shares Outstanding | -- | 2.24% | 1.38% | 1.31% | 1.15% |
| Average Diluted Shares Outstanding | -- | 2.24% | 1.38% | 1.31% | 1.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |